Summit Therapeutics Inc (SMMT)
15.72
-2.48%
Summit Therapeutics Inc (SMMT) is currently trading at $15.72. This represents a loss of 2.48% from the previous session. With a market capitalization of $12.20B, SMMT is a key component of the Health Care sector. Investors looking to trade SMMT should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade SMMT commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Summit Therapeutics Inc (SMMT) shows a bearish trend. Analysts are watching the 16.51 level closely.
Fundamentals
Mkt Cap12.20B
P/E Ratio0.0000
Volume733,637
60-Day Technical Chart
Advanced Charting
Need more indicators for SMMT? Use the world's #1 platform.
Open SMMT on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $16
| Metric |
SMMT -2.48% |
F +1.30% |
HIMS +5.27% |
LUNR -13.81% |
|---|---|---|---|---|
| Price | $15.72 | $14.38 | $16.25 | $16.30 |
| Mkt Cap | $12.20B | $57.39B | $3.72B | $3.32B |
| - | View → | View → | View → |
Latest Headlines
Summit Therapeutics posts $1.08B loss, FDA accepts lung cancer BLA
Stock Titan • Feb 23, 2026
SMMT: Analyst Lowers Price Target to $30, Maintains Buy Rating |
GuruFocus • Feb 24, 2026
Summit Therapeutics (SMMT) Valuation Check After Recent Share Price Pullback And Conflicting Model Signals
Yahoo Finance • Jan 30, 2026
$SMMT stock is down 5% today. Here's what we see in our data.
Quiver Quantitative • Jan 23, 2026
Assessing Summit Therapeutics (SMMT) Valuation After Ivonescimab FDA Filing And New GSK Trial Collaboration
Sahm • Jan 14, 2026
● Gemini Agentic AI Analyst Insight for SMMT
Market Education
- Exploring Gann Trading: An Insightful Guide for Traders Jun 2, 2024
- Finding Stocks in the Squeeze Zone: Using Finviz Jul 30, 2023
- What is Pattern Day Trading rule (PDT) - Its limiting my trading. Jul 15, 2023
External Research